160 related articles for article (PubMed ID: 28885299)
1. Correlates of Stigma Severity Among Persons Seeking Opioid Detoxification.
Bozinoff N; Anderson BJ; Bailey GL; Stein MD
J Addict Med; 2018; 12(1):19-23. PubMed ID: 28885299
[TBL] [Abstract][Full Text] [Related]
2. A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: Evidence for construct validity.
Yang LH; Grivel MM; Anderson B; Bailey GL; Opler M; Wong LY; Stein MD
J Subst Abuse Treat; 2019 Apr; 99():44-51. PubMed ID: 30797393
[TBL] [Abstract][Full Text] [Related]
3. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
4. Long-term relapse of ultra-rapid opioid detoxification.
Salimi A; Safari F; Mohajerani SA; Hashemian M; Kolahi AA; Mottaghi K
J Addict Dis; 2014; 33(1):33-40. PubMed ID: 24471478
[TBL] [Abstract][Full Text] [Related]
5. Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Care Professionals: A Randomized Clinical Trial.
Kennedy-Hendricks A; McGinty EE; Summers A; Krenn S; Fingerhood MI; Barry CL
JAMA Netw Open; 2022 Feb; 5(2):e2146971. PubMed ID: 35119460
[TBL] [Abstract][Full Text] [Related]
6. Social Stigma toward Persons with Opioid Use Disorder: Results from a Nationally Representative Survey of U.S. Adults.
Taylor BG; Lamuda PA; Flanagan E; Watts E; Pollack H; Schneider J
Subst Use Misuse; 2021; 56(12):1752-1764. PubMed ID: 34315335
[No Abstract] [Full Text] [Related]
7. Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder.
Stein MD; Conti MT; Kenney S; Anderson BJ; Flori JN; Risi MM; Bailey GL
Drug Alcohol Depend; 2017 Oct; 179():325-329. PubMed ID: 28841495
[TBL] [Abstract][Full Text] [Related]
8. First-Year Medical Students' Perceptions of Stigma Toward People With Opioid Use Disorder Before and After an Educational Intervention.
Graves RL; Shofer FS; Kayser JB; Perrone J
Subst Use Addctn J; 2024 Jul; 45(3):486-492. PubMed ID: 38456439
[TBL] [Abstract][Full Text] [Related]
9. Perceived need for depression treatment among persons entering inpatient opioid detoxification.
Stein MD; Santiago Rivera OJ; Anderson BJ; Bailey GL
Am J Addict; 2017 Jun; 26(4):395-399. PubMed ID: 28453912
[TBL] [Abstract][Full Text] [Related]
10. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.
Bisaga A; Sullivan MA; Glass A; Mishlen K; Pavlicova M; Haney M; Raby WN; Levin FR; Carpenter KM; Mariani JJ; Nunes EV
Drug Alcohol Depend; 2015 Sep; 154():38-45. PubMed ID: 26187456
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
[TBL] [Abstract][Full Text] [Related]
12. Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.
Sullivan M; Bisaga A; Pavlicova M; Choi CJ; Mishlen K; Carpenter KM; Levin FR; Dakwar E; Mariani JJ; Nunes EV
Am J Psychiatry; 2017 May; 174(5):459-467. PubMed ID: 28068780
[TBL] [Abstract][Full Text] [Related]
13. Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults.
Adams ZW; Taylor BG; Flanagan E; Kwon E; Johnson-Kwochka AV; Elkington KS; Becan JE; Aalsma MC
J Adolesc Health; 2021 Aug; 69(2):321-328. PubMed ID: 33579622
[TBL] [Abstract][Full Text] [Related]
14. Perceived stigma and social support in treatment for pharmaceutical opioid dependence.
Cooper S; Campbell G; Larance B; Murnion B; Nielsen S
Drug Alcohol Rev; 2018 Feb; 37(2):262-272. PubMed ID: 28884866
[TBL] [Abstract][Full Text] [Related]
15. The influence of anxiety sensitivity on opioid use disorder treatment outcomes.
Baxley C; Weinstock J; Lustman PJ; Garner AA
Exp Clin Psychopharmacol; 2019 Feb; 27(1):64-77. PubMed ID: 30080059
[TBL] [Abstract][Full Text] [Related]
16. Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.
Stein MD; Kenney SR; Anderson BJ; Conti MT; Bailey GL
J Subst Abuse Treat; 2020 Mar; 110():37-41. PubMed ID: 31952626
[TBL] [Abstract][Full Text] [Related]
17. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports.
Miller NS; Swiney T; Barkin RL
Am J Ther; 2006; 13(5):436-44. PubMed ID: 16988540
[TBL] [Abstract][Full Text] [Related]
18. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V
Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846
[TBL] [Abstract][Full Text] [Related]
19. Cost and utilization outcomes of opioid-dependence treatments.
Baser O; Chalk M; Fiellin DA; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S235-48. PubMed ID: 21761950
[TBL] [Abstract][Full Text] [Related]
20. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
